NEW YORK (GenomeWeb) – Baylor Genetics and Rainbow Genomics announced on Monday a partnership to offer clinical exome sequencing tests to patients in Asia.

Hong Kong-based Rainbow Genomics will offer screening and diagnostic exome sequencing-based tests developed by Baylor, including one to assess risk for developing a genetic disorder, a test to assess cancer risk, and a diagnostic cancer test. In addition, Rainbow will use Baylor's Consultagene service to offer bilingual genetic counseling in English, Mandarin, Cantonese, and Japanese.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.